Calton & Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,178
Closed -$207K 311
2018
Q3
$207K Buy
+2,178
New +$186K 0.06% 261
2018
Q2
Sell
-3,271
Closed -$226K 405
2018
Q1
$226K Buy
3,271
+374
+13% +$28.5K 0.07% 306
2017
Q4
$235K Buy
+2,897
New +$185K 0.06% 303

Other funds holding ESRX

Calton & Associates's ESRX Position: Q4 2018 in Review

Calton & Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 2,178 shares — an estimated $207K sold.

Calton & Associates first reported a position in ESRX in Q4 2017 and held it in 3 quarters. The position peaked at $235K in Q4 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Calton & Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Calton & Associates sold 2,178 Express Scripts Holding Company shares in Q4 2018, an estimated $207K.
  • Calton & Associates first reported a position in Express Scripts Holding Company in Q4 2017 and held it in 3 quarters.
  • Calton & Associates's Express Scripts Holding Company position peaked at $235K in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Calton & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.